Floatz logo

Therapeutic Asset Ratings

5,099 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Adenocarcinoma
M.D. Anderson Cancer CenterP3B (62)
Pembrolizumab
Head And Neck Neoplasm
Mayo ClinicP3B (62)
Pembrolizumab
Renal Pelvis Urothelial Carcinoma
Fred Hutchinson Cancer CenterP3B (62)
Pembrolizumab
Ureter Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP3B (62)
Pembrolizumab
Prostate Cancer
Icahn School of Medicine at Mount SinaiP3B (62)
Pembrolizumab
Uterine Cervix Neoplasm
GV20 TherapeuticsP3B (62)
Pertuzumab
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer InstituteP3B (62)
Phenserine
Parkinson Disease
Annovis Bio Inc.P3B (62)
Polatuzumab Vedotin
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Ruijin HospitalP3B (62)
Ponatinib
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
University of AlbertaP3B (62)
Ponesimod
Multiple Sclerosis
BiogenP3B (62)
Pralatrexate
T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer CenterP3B (62)
Prednisolone
Diffuse Large B-Cell Lymphoma
Mwanasha Merrill, MDP3B (62)
Prednisone
Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-JosephP3B (62)
Prednisone
Acute Undifferentiated Leukemia
Syndax PharmaceuticalsP3B (62)
Prednisone
Hypogonadism
SWOG Cancer Research NetworkP3B (62)
Prednisone
Large B-Cell Lymphoma
Ruijin HospitalP3B (62)
Prednisone
Lymphoblastic Lymphoma
University of WashingtonP3B (62)
Prednisone
Renal Cell Carcinoma
ExelixisP3B (62)
Prednisone
Neoplasm
The First Affiliated Hospital of Soochow UniversityP3B (62)
Raltitrexed
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3B (62)
Ranitidine
Plasma Cell Myeloma
Hoffmann-La RocheP3B (62)
Regorafenib
Hepatocellular Carcinoma
University of MiamiP3B (62)
Relugolix
Prostate Adenocarcinoma
National Cancer Institute, NaplesP3B (62)
Ribociclib
Luminal B Breast Carcinoma
Danish Breast Cancer Cooperative GroupP3B (62)
Showing 1901 to 1925 of 5,099 assets
PreviousPage 77 of 204Next